Skip to main content
Erschienen in: BMC Gastroenterology 1/2019

Open Access 01.12.2019 | Research article

Impact of visceral adiposity on severity of acute pancreatitis: a propensity score-matched analysis

verfasst von: Jiarong Xie, Lu Xu, Yuning Pan, Peifei Li, Yi Liu, Yue Pan, Lei Xu

Erschienen in: BMC Gastroenterology | Ausgabe 1/2019

Abstract

Background

The relationship between visceral adiposity and acute pancreatitis (AP) has not been completely elucidated. This study evaluated the significance of visceral adipose tissue (VAT) and the ratio of VAT to skeletal muscle tissue (VAT/SMT) in the prognosis of AP patients.

Methods

Based on a 1:2 propensity score matching, 306 hospitalized patients were enrolled in the study analysis from 2010 to 2017. VAT, subcutaneous adipose tissue (SAT), and SMT were measured using unenhanced computed tomography (CT). Cox proportional hazards models were applied for the analysis.

Results

VAT and the VAT/SMT ratio were significantly higher in the severe AP (SAP) and moderately severe AP (MSAP) groups compared to the mild AP (MAP) group (both p < 0.001). Intensive care transfer, AP severity, systemic complications, and prognostic scores (Acute Physiology and Chronic Health Evaluation II [APACHE-II] score ≥ 8, Ranson’s score ≥ 3, Bedside Index of Severity in Acute Pancreatitis [BISAP] score ≥ 3, and the systemic inflammatory response syndrome [SIRS] score ≥ 2) significantly correlated with VAT and the VAT/SMT ratio in AP patients. The multivariate adjusted hazard ratios (HRs) for VAT and the VAT/SMT ratio in the relationship of body parameters and AP mortality were 1.042 (95% confidence interval (CI), 1.019–1.066) and 7.820 (95% CI, 1.978–30.917), respectively. Compared with other prognostic scores, VAT had the highest area under the curve of receiver operating characteristics (ROC) (0.943, 95% CI, 0.909–0.976).

Conclusion

High VAT and VAT/SMT ratio are independent negative prognostic indicators of AP.

Trial registration

Clinical study registration number: NCT03482921. Date of registration: 03/23/2018.
Hinweise
Jiarong Xie and Lu Xu contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ANC
Acute necrotic collection
AP
Acute pancreatitis
APACHE-II
Acute Physiology and Chronic Health Evaluation II
APFC
Acute peripancreatic fluid collection
BISAP
Bedside Index of Severity in Acute Pancreatitis
BMI
Body mass index
CT
Computed tomography
ICU
Intensive care unit
MAP
Mild acute pancreatitis
MRI
Magnetic resonance imaging
ROC
Receiver operating characteristic
SAP
Severe acute pancreatitis
SIRS
Systemic inflammatory response syndrome
SMT
Skeletal muscle tissue
VAT
Visceral adipose tissue
WON
Walled-off necrosis

Background

Acute pancreatitis (AP) is cause by inflammation of the pancreas. In the majority of cases, AP is mild and self-limited. However, about 20% of AP patients experience severe complications with a high risk of mortality [1, 2]. It is vital to classify severe AP cases early in the evolution of the disease, because severe cases require more aggressive treatment to achieve the best possible results and reduce complications [3]. Historically, several scoring systems have been developed and widely utilized to determine AP severity: Acute Physiology and Chronic Health Evaluation II (APACHE-II) score, Bedside Index of Severity in Acute Pancreatitis (BISAP) score, and Ranson’s score [46]. Each of these scoring systems has its advantages and limitations. Other systems have also been developed and many others are currently being created. However, it has remained difficult to identify the most effective method to predict AP severity at an early stage.
It is well-established that obesity (defined as body mass index (BMI) > 30 kg/m2 by the World Health Organization) is a risk factor for AP severity and increases the incidence of systemic complications and mortality [79]. BMI measurements and waist circumference are often viewed as indicators of being overweight. One disadvantage of these parameters is that they do not distinguish between truncal obesity and visceral obesity. This is significant because fat distribution plays an important role in AP severity. In recent years, many parameters related to sarcopenic obesity, including visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), skeletal muscle tissue (SMT), and the VAT/SMT ratio, have been considered important risk factors of AP [1013]. Some recent reports indicated that increased VAT is more closely associated with AP severity compared to BMI [10, 1416]. However, it is unclear which parameter is the best predictor of AP severity [17]. There are very few studies in the literature that address the association between body composition parameters and clinical outcomes in AP. Thus, this study explored the association between these parameters and AP severity to elucidate which is the most suitable predictor of AP.

Methods

Study population

We analyzed 1662 consecutive hospitalized patients with AP between August 1st, 2010 and August 31st, 2017 at Ningbo First Hospital, China. This study was approved by the Human Ethics Committee. The clinical study registration number is NCT03482921. Severe AP (SAP) and moderately severe AP (MSAP) were defined in 111 patients according to the Revised Atlanta Classification of AP [18] (Fig. 1). Exclusion criteria for the study included age < 18 years, missing data in the electronic medical record, and history of AP. Nine unqualified patients were excluded. SPSS R plug-in (SPSS R Essentials) was applied for matching [19]. We used the SPSS “PS Matching” feature to perform propensity score-matched analysis. Matching factors include age, sex, and BMI. SAP, and MSAP patients were matched 1:2 in a multivariable logistic analysis using stepwise regression based on a greedy matching algorithm with a caliper of 0.2 times the standard deviation (SD) of the logit. After applying 1:2 propensity score matching, 102 eligible patients were matched to 204 patients with mild AP (MAP). In total, 306 hospitalized patients were enrolled in this study.

Severity assessment

AP severity was defined using the Revised Atlanta Classification criteria. The clinical classification defined 3 grades of severity: MAP, MSAP, and SAP.

Definition of systemic complications

Systemic complication was defined as a score ≥ 2 in one of three assessed organ systems (respiratory, cardiovascular, or renal) according to the modified Marshall scoring system [20].

Definition of local complications

Local complications of AP were divided into: acute peri-pancreatic fluid collection (APFC), acute necrotic collection (ANC), pancreatic pseudocyst, and walled-off necrosis (WON). Diagnosis of local complication on unenhanced computed tomography (CT) was evaluated by two experienced radiologists who were blinded to detailed information about the cases. When necessary, follow-up contrast-enhanced CT (CECT) and magnetic resonance imaging (MRI) are performed based on the clinical status of patients, including persistence or recurrence of abdominal pain, increasing organ dysfunction, and development of clinical signs of sepsis. Once patients are diagnosed with APFC, ANC, WON, or pseudocyst in the follow-up imaging examinations, they are considered to present with local complications.

Laboratory tests

Creatinine, calcium, and albumin levels obtained within the first 24 h were collected for each patient. Additional variables included intensive care unit (ICU) requirement, length of hospital stay, and in-hospital mortality.

Combined scoring systems

The APACHE-II, BISAP, and SIRS scores were calculated within the first 24 h of admission, and Ranson’s score was recorded within 48 h of admission.

CT and image analysis

A dual 16-slice CT scanner (SIMENS SOMATOM Sensation; Siemens, Germany) was used for entire / upper abdominal CT at 250 mA; tube voltage, 120 kV; data collection thickness 5 mm; reconstruction thickness 1 mm; and reconstruction interval 1 mm. CT scans were performed within 24 h after patient admission. Entire abdomen CT was performed to 165 patients. Upper abdomen CT was performed to 141 patients. Two consecutive, axial images on unenhanced CT at the L3/4 intervertebral space were retrospectively reviewed by two radiologists who were blinded to patient information. We calculated fat and muscle cross-sectional areas, which have been validated as the best proxies of SAT and VAT independent of age [21]. Skeletal muscle areas, including the psoas, paraspinal, and the abdominal wall muscles excluding the intra-abdominal visceral muscles, were also measured (Fig. 2). We used the Photoshop “magic wand” to outline and measure regions of similar signal intensity based on pixel counts. We manually outlined the margin of fat deposition manually in fat-tissue regions with poor contrast, which may be a more accurate way to measure compartment volumes. The Hounsfield units (HU) range for adipose tissue was − 190 to − 30 HU [22]. The mean value of the two images was calculated. The abdominal muscular wall distinguishing between VAT and SAT was traced automatically and adjusted manually [23, 24]. The VAT/SMT ratio was calculated by dividing VAT by SMT. All CT scans were analyzed using a commercially available software program (Photoshop CS6, Adobe Systems, CA) [25].

Statistical analysis

Continuous variables are expressed as mean ± standard deviation (SD) and median (interquartile range). Categorical outcomes are presented as frequencies and proportions. Comparisons of different variables were performed using one-way analysis of variance (ANOVA) and Likelihood Ratio. Cox regression analysis adjusted for confounders were used to identify the relationships. Discrimination of the predicting factors, including VAT and VAT/SMT ratio, were accomplished via receiver operating characteristic (ROC) curves. A two-tailed p value < 0.05 was considered statistically significant. All statistical analyses were performed using SPSS software (version 23.0; SPSS, Chicago, IL).

Results

Baseline characteristics

In this study, every MSAP and SAP patient was propensity score matched with another MAP patient at a ratio of 1:2. Finally, 306 hospitalized patients were enrolled for further analysis. Among the 306 patients, causative factors of AP included gallstone-related (142; 46.4%), idiopathic (91; 29.7%), hypertriglyceridemia (48; 15.7%), alcohol abuse (22; 7.2%), and others (3;1.0%). The mean age of the patients was 50.6 ± 18.7 years. The mean estimated BMI was 24.4 ± 4.5 kg/m2. The mean SAT value was 131.1 ± 23.1 cm2. The mean VAT value was 136.1 ± 27.3 cm2. The mean SMT value was 138.2 ± 25.8 cm2.

Comparisons of characteristics according to AP severity

Age, sex, and BMI distribution were not statistically different among groups after propensity matching. There was a significant association between AP severity and individual fat parameters, except for SAT (Table 1). VAT and the VAT/SMT ratio were significantly higher in the MSAP and SAP groups compared to the MAP group (both p < 0.001). The mean SMT values decreased as AP severity increased (p < 0.001).
Table 1
Clinical characteristics of patients stratified by AP severity
 
Total
Severity of AP
p value
Mild
Moderately severe
Severe
(n = 306)
(n = 204)
(n = 56)
(n = 46)
Age (years)
50.6 ± 18.7
50.4 ± 18.7
49.4 ± 18.9
52.8 ± 19.3
0.632
Sex, male (%)
157 (51.3%)
107 (52.5%)
25 (44.6%)
25 (54.3%)
0.552
BMI (kg/m2)
24.4 ± 4.5
24.2 ± 5.0
24.7 ± 2.7
25.3 ± 3.1
0.505
Fat volume parameters (cm2)
 SAT
131.1 ± 23.1
128.1 ± 22.1
138.8 ± 22.4
134.6 ± 25.8
0.04
 VAT
136.1 ± 27.3
121.6 ± 17.3
154.1 ± 15.1
178.7 ± 15.2
< 0.001
 SMT
138.2 ± 25.8
143.5 ± 25.8
130.6 ± 20.2
123.7 ± 24.5
< 0.001
 VAT/SMT ratio
1.03 ± 0.32
0.87 ± 0.21
1.21 ± 0.21
1.49 ± 0.26
< 0.001
BMI, Body mass index; SAT, Subcutaneous adipose tissue; VAT, Visceral adipose tissue; SMT, Skeletal muscle tissue
Student Newman-Keuls post hoc comparisons of fat volume parameters were assessed between three groups (p < 0.05, respectively)

Relationship between body parameters and severity outcomes

Based on the VAT value at the L3/4 intervertebral space, patients were separated into five groups. ICU transfer, AP severity, and systemic complications (APACHE-II scores ≥8, BISAP score ≥ 3, SIRS score ≥ 2) were significantly related to VAT values in the AP patients (Table 2).
Table 2
Relationships between VAT and severity outcomes
VAT(cm2)
< 90
90–120
120–150
150–180
> 180
p value
Number of patients
7
97
103
69
30
 
ICU transfer
0 (0%)
2 (2.1%)
5 (4.9%)
27 (39.1%)
24 (80.0%)
< 0.001
SAP
0 (0%)
0 (0%)
4 (3.9%)
13 (18.8%)
29 (96.7%)
< 0.001
Mortality
0 (0%)
0 (0%)
4 (3.9%)
8 (11.6%)
15 (50%)
< 0.001
Systemic complications
0 (0%)
3 (3.1%)
10 (9.7%)
40 (58.0%)
29 (96.7%)
< 0.001
Local complications
 APFC
2 (28.6%)
38 (39.2%)
28 (27.2%)
26 (37.7%)
16 (53.3%)
0.107
 ANC
0 (0%)
0 (0%)
0 (0%)
8 (11.6%)
3 (10.0%)
< 0.001
 WON
0 (0%)
1 (1.0%)
5 (4.9%)
6 (8.7%)
4 (13.3%)
0.038
 Pancreatic pseudocyst
0 (0%)
2 (2.1%)
6 (5.8%)
8 (11.6%)
3 (10.0%)
0.088
Prognostic scores
 APACHE-II score ≥ 8
0 (0%)
7 (7.2%)
8 (7.8%)
17 (24.6%)
21 (70.0%)
< 0.001
 Ranson’s score ≥ 3
0 (0%)
7 (7.2%)
6 (5.8%)
9 (13.0%)
14 (46.7%)
< 0.001
 BISAP score ≥ 3
0 (0%)
2 (2.1%)
3 (2.9%)
4 (5.8%)
5 (16.7%)
0.048
 SIRS score ≥ 2
1 (14.3%)
12 (12.4%)
22 (21.4%)
40 (58.0%)
21 (70.0%)
< 0.001
VAT, Visceral adipose tissue; ICU, Intensive care unit; SAP, Severe acute pancreatitis; APFC, Acute peripancreatic fluid collection; ANC, Acute necrotic collection; WON, Walled-off necrosis; APACHE-II, Acute Physiology and Chronic Health Evaluation II; BISAP, Bedside Index of Severity in Acute Pancreatitis; SIRS, systemic inflammatory response syndrome
Patients were also separated into five groups according to the VAT/SMT ratio. ICU transfer, AP severity, systemic complications, and prognostic scores (APACHE-II scores ≥8, Ranson’s score ≥ 3, BISAP score ≥ 3, SIRS score ≥ 2) had significant relationship with the VAT/SMT ratio (Table 3).
Table 3
Relationship between the VAT/SMT ratio and severity outcomes
VAT/SMT ratio
< 0.6
0.6–0.9
0.9–1.2
1.2–1.5
> 1.5
p value
Number of patients
7
147
60
56
36
 
ICU transfer
0 (0%)
5 (3.4%)
6 (10.0%)
22 (39.3%)
25 (69.4%)
< 0.001
SAP
0 (0%)
2 (1.4%)
5 (8.3%)
11 (19.6%)
28 (77.8%)
< 0.001
Mortality
0 (0%)
2 (1.4%)
4 (6.7%)
8 (14.3%)
13 (36.1%)
< 0.001
Systemic complications
0 (0%)
7 (4.8%)
19 (31.7%)
28 (50%)
28 (77.8%)
< 0.001
Local complications
 APFC
2 (28.6%)
49 (33.3%)
22 (36.7%)
22 (39.3%)
15 (41.7%)
0.859
 ANC
0 (0%)
0 (0%)
4 (6.7%)
5 (8.9%)
2 (5.6%)
0.002
 WON
0 (0%)
2 (1.4%)
5 (8.3%)
4 (7.1%)
5 (13.9%)
0.017
 Pancreatic pseudocyst
0 (0%)
2 (1.4%)
3 (5.0%)
9 (16.1%)
5 (13.9%)
0.01
Prognostic scores
 APACHE-II score ≥ 8
0 (0%)
13 (8.8%)
8 (13.3%)
13 (23.2%)
19 (52.8%)
< 0.001
 Ranson’s score ≥ 3
0 (0%)
9 (6.1%)
6 (10.0%)
8 (14.3%)
13 (36.1%)
< 0.001
 BISAP score ≥ 3
0 (0%)
2 (1.4%)
1 (1.7%)
5 (8.9%)
6 (16.7%)
0.002
 SIRS score ≥ 2
1 (14.3%)
22 (15.0%)
17 (28.3%)
32 (57.1%)
24 (66.7%)
< 0.001
VAT, Visceral adipose tissue; SMT, Skeletal muscle tissue; ICU, Intensive care unit; SAP, Severe acute pancreatitis; APFC, Acute peripancreatic fluid collection; ANC, Acute necrotic collection; WON, Walled-off necrosis; APACHE-II, Acute Physiology and Chronic Health Evaluation II; BISAP, Bedside Index of Severity in Acute Pancreatitis; SIRS, Systemic inflammatory response syndrome

Confounding variables

Further analyses were conducted for creatinine, calcium, and albumin levels using an adjusted model (Table 4). The multivariate adjusted hazard ratios (HRs) for VAT and the VAT/SMT ratio in the relationship between body parameters and AP mortality were 1.042 (95% confidence interval (CI), 1.019–1.066) and 7.820 (95% CI, 1.978–30.917), respectively. The VAT/SMT ratio was positively related to the incidence of AP mortality (p < 0.001).
Table 4
Multivariate adjusted HRs and 95% CIs for the association between body parameters and AP mortality
Variables
All of the participants(n = 264)
Model1
Model2
HR (95% CI)
p value
HR (95% CI)
p value
VAT, cm2
1.042 (1.019–1.066)
< 0.001
  
VAT/SMT ratio
  
7.820 (1.978–30.917)
0.003
Creatinine
1.003 (1.001–1.006)
0.014
1.004 (1.001–1.007)
0.005
Calcium
0.498 (0.103–2.413)
0.387
0.232 (0.045–1.184)
0.079
Albumin
0.986 (0.921–1.056)
0.682
0.992 (0.925–1.063)
0.812
VAT, visceral adipose tissue; SMT, skeletal muscle tissue
Model 1 and model 2 were based on the VAT and the VAT/SMT ratio, respectively. Cox proportional hazard models were used to estimate the HRs, 95% Cis, and p values

Comparisons of independent predictors

The AUCs were measured to evaluate individual fat parameters of VAT and the VAT/SMT ratio for predicting the incidence of SAP and MSAP, ICU stay, and the incidence of WON (Fig. 3).
VAT had the highest area under the curve of ROC (0.943, 95% CI, 0.909–0.976) for predicting the incidence of SAP and MSAP, among independent predictors. The AUC of the VAT/SMT ratio was also significantly higher compared to the predictive scoring systems (0.896, 95% CI, 0.856–0.936). The optimal cut-off value of VAT for the prognosis of AP was 145.0. The sensitivity and specificity of this cut-off value were 90.2 and 93.1%, respectively. The optimal cut-off point of the VAT/SMT ratio for the prognosis of AP was 0.706. The sensitivity and specificity of this cut-off value were 80.4 and 90.2%, respectively. The cut-off values for VAT and the VAT/SMT ratio can be used to predict the incidence of SAP and MSAP.
We also demonstrated that VAT and the VAT/SMT ratio had high sensitivity and specificity for predicting the incidence of ICU stay and WON compared to other predictive scoring systems. The AUC of VAT for predicting the incidence of ICU stay was 0.900 (95% CI, 0.851–0.949). The second highest AUC of ROC was the VAT/SMT ratio (0.865, 95% CI, 0.810–0.921). The AUC of the VAT/SMT ratio was the highest predictor of the incidence WON (0.745, 95% CI, 0.628–0.863).

Discussion

This propensity score-matched, case-control study assessed the significance of VAT and the VAT/SMT ratio as AP prognostic factors. VAT and the VAT/SMT ratio increased as AP severity increased, including the incidence of SAP and MSAP, the incidence of ICU transfer, and the incidence of WON. This study also calculated the optimal cut-off values, which can be used to predict AP severity.
AP involves sudden inflammation in the pancreas. Early prediction of SAP will allow more aggressive management at early stages of the disease. There are many SAP predictive scoring systems. However, none can predict the severity at early stages of AP. If initial CT scans in AP patients are routinely performed at an early stage, the values of VAT and the VAT/SMT ratio could be quickly calculated and used as predictors.
Obesity is a well-established risk factor of severity and mortality in AP patients [9, 26]. In previous studies, obesity was determined as BMI > 30 kg/m2. However, Asians tend to have a significantly lower BMI, at approximately 2–3 kg/m2 lower compared to age and sex matched whites with the same amount of body fat [27]. Currently, there is no universal tool to predict prognosis and mortality in AP patients [2833]. In addition, the scoring tools do not distinguish between truncal obesity and visceral obesity. Some studies showed that VAT significantly correlates with poor outcomes in AP patients [10, 1416]. Therefore, we investigated the relationship between body parameters, prognosis, and mortality in AP patients. This study showed that VAT and the VAT/SMT ratio were significantly higher in the MSAP and SAP groups compared to the MAP group. Besides, VAT, and VAT/SMT ratio had the highest AUC in predicting the incidence of SAP and MSAP, the incidence of ICU transfer, and the incidence of WON. VAT and the VAT/SMT ration could therefore be used to distinguish AP severity by applying VAT and the VAT/SMT ratio scoring in clinical practice.
Previous studies reported gender-based variations in fat distribution, especially in obese patients [34, 35]. Risk of disease, as well as visceral fat, increases dramatically with age [36, 37]. In our study, every high-risk case was propensity score matched at a 1:2 ratio with another patient with MAP. Matching was based on patient demographics (age, sex, and BMI), which decreased bias and effectively controlled for confounding variables. Some clinical characteristics, such as creatinine, calcium, and albumin levels, are typically considered biomarkers associated with disease prognosis and mortality. These characteristics have often been considered in the AP scoring systems [4, 38, 39]. We used Cox proportional hazard models adjusted for creatinine, calcium, and albumin levels, which may reduce the bias. The mean value of two images were reviewed by two dedicated radiologists blinded to clinical and demographic data to increase the accuracy of our results.
There are four studies that have presented similar results to the finding described here. A study of 62 cases [15] reported a close relationship between AP severity, systemic complications, and individual fat parameters. Another study of 124 patients [14] demonstrated that VAT volume is significantly associated with SAP but not BMI or waist circumference. Yoon et al. [10] found that high visceral fat with low skeletal muscle volume plays an important role in AP severity. Natu et al. [16] found that VAT is closely associated with organ failure and necrosis in AP. However, there are some limitations. Some of these studies did not focus on body parameter classifications. Furthermore, they did not provide clinical characteristics of the patients, such as creatinine, calcium, and albumin, which could act as confounding variables. Moreover, since the first two studies were published before the revised version appeared, they used the previous version of the Atlanta classification, which is not as precise as other measures. Our study investigated the relationship between different body parameters and AP severity. To our knowledge, this study is the largest describing these parameters.
There are several limitations in our study. First, at present, it is difficult to perform a CT scan on a patient within 24 h after admission in some countries and regions. Second, due to its retrospective design, the statistical power of analysis is relatively weak. Third, individuals from the Chinese population were included in our study. We did not recruit AP patients in western countries, which may increase potential bias.
This is the largest study exploring the relationship between different body parameters and severity of AP after taking several covariates into account. Furthermore, we calculated the optimal cut-off value of VAT and the VAT/SMT ratio. Therefore, VAT and the VAT/SMT ratio should be considered as independent predictors in AP patients. To extend our results to clinical-decision making, further randomized, multi-center, prospective studies that include different countries and regions are needed to better assess the association between visceral adiposity with severity of AP.

Conclusions

The results of this study suggest that VAT and the VAT/SMT ratio are strong predictors of severity, mortality, and systemic complications in AP patients.

Acknowledgments

Not applicable.
The study was approved by the Ethics Committee at Ningbo First Hospital, China (No. 2018-R013). Written informed consent of each patient was waived as it was a retrospective study.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA. 2004;291(23):2865–8.CrossRef Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA. 2004;291(23):2865–8.CrossRef
2.
Zurück zum Zitat Whitcomb DC. Acute pancreatitis. N Engl J Med. 2006;354(20):2142–50.CrossRef Whitcomb DC. Acute pancreatitis. N Engl J Med. 2006;354(20):2142–50.CrossRef
3.
Zurück zum Zitat Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101(10):2379.CrossRef Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101(10):2379.CrossRef
4.
Zurück zum Zitat Larvin M, Mcmahon M. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet. 1989;334(8656):201–5.CrossRef Larvin M, Mcmahon M. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet. 1989;334(8656):201–5.CrossRef
5.
Zurück zum Zitat Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut. 2008;57(12):1698–703.CrossRef Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut. 2008;57(12):1698–703.CrossRef
6.
Zurück zum Zitat Ranson JH, Pasternack BS. Statistical methods for quantifying the severity of clinical acute pancreatitis. J Surg Res. 1977;22(2):79–91.CrossRef Ranson JH, Pasternack BS. Statistical methods for quantifying the severity of clinical acute pancreatitis. J Surg Res. 1977;22(2):79–91.CrossRef
7.
Zurück zum Zitat Hilal MA, Armstrong T. The impact of obesity on the course and outcome of acute pancreatitis. Obes Surg. 2008;18(3):326–8.CrossRef Hilal MA, Armstrong T. The impact of obesity on the course and outcome of acute pancreatitis. Obes Surg. 2008;18(3):326–8.CrossRef
8.
Zurück zum Zitat Martinez J, Sanchez-Paya J, Palazon J, Suazo-Barahona J, Robles-Diaz G, Perez-Mateo M. Is obesity a risk factor in acute pancreatitis? A meta-analysis. Pancreatology. 2004;4(1):42–8.CrossRef Martinez J, Sanchez-Paya J, Palazon J, Suazo-Barahona J, Robles-Diaz G, Perez-Mateo M. Is obesity a risk factor in acute pancreatitis? A meta-analysis. Pancreatology. 2004;4(1):42–8.CrossRef
9.
Zurück zum Zitat Martinez J, Johnson C, Sanchez-Paya J, De Madaria E, Robles-Diaz G, Perez-Mateo M. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology. 2006;6(3):206–9.CrossRef Martinez J, Johnson C, Sanchez-Paya J, De Madaria E, Robles-Diaz G, Perez-Mateo M. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology. 2006;6(3):206–9.CrossRef
10.
Zurück zum Zitat Yoon SB, Choi MH, Lee IS, Lim C-H, Kim JS, Cho YK, Park JM, Lee B-I, Cho Y-S, Choi M-G. Impact of body fat and muscle distribution on severity of acute pancreatitis. Pancreatology. 2017;17(2):188–93.CrossRef Yoon SB, Choi MH, Lee IS, Lim C-H, Kim JS, Cho YK, Park JM, Lee B-I, Cho Y-S, Choi M-G. Impact of body fat and muscle distribution on severity of acute pancreatitis. Pancreatology. 2017;17(2):188–93.CrossRef
11.
Zurück zum Zitat Sadr-Azodi O, ., Orsini N, ., ? A-S, Wolk a, . Abdominal and total adiposity and the risk of acute pancreatitis: a population-based prospective cohort study. Am J Gastroenterol 2013, 108(1):133–139.CrossRef Sadr-Azodi O, ., Orsini N, ., ? A-S, Wolk a, . Abdominal and total adiposity and the risk of acute pancreatitis: a population-based prospective cohort study. Am J Gastroenterol 2013, 108(1):133–139.CrossRef
12.
Zurück zum Zitat Sempere L, Martinez J, De Madaria E, Lozano B, Sanchez-Paya J, Jover R, Perez-Mateo M. Obesity and fat distribution imply a greater systemic inflammatory response and a worse prognosis in acute pancreatitis. Pancreatology. 2008;8(3):257–64.CrossRef Sempere L, Martinez J, De Madaria E, Lozano B, Sanchez-Paya J, Jover R, Perez-Mateo M. Obesity and fat distribution imply a greater systemic inflammatory response and a worse prognosis in acute pancreatitis. Pancreatology. 2008;8(3):257–64.CrossRef
13.
Zurück zum Zitat Ji T, Li X, Zhang X, Hui L, Shang F, Zhu X, Guo L, Xu Y. Evaluation of the severity of hyperlipidemia pancreatitis using CT-measured visceral adipose tissue. J Clin Gastroenterol. 2018. Ji T, Li X, Zhang X, Hui L, Shang F, Zhu X, Guo L, Xu Y. Evaluation of the severity of hyperlipidemia pancreatitis using CT-measured visceral adipose tissue. J Clin Gastroenterol. 2018.
14.
Zurück zum Zitat Yashima Y, Isayama H, Tsujino T, Nagano R, Yamamoto K, Mizuno S, Yagioka H, Kawakubo K, Sasaki T, Kogure H. A large volume of visceral adipose tissue leads to severe acute pancreatitis. J Gastroenterol. 2011;46(10):1213.CrossRef Yashima Y, Isayama H, Tsujino T, Nagano R, Yamamoto K, Mizuno S, Yagioka H, Kawakubo K, Sasaki T, Kogure H. A large volume of visceral adipose tissue leads to severe acute pancreatitis. J Gastroenterol. 2011;46(10):1213.CrossRef
15.
Zurück zum Zitat O’Leary D, O’Neill D, McLaughlin P, O’Neill S, Myers E, Maher M, Redmond H. Effects of abdominal fat distribution parameters on severity of acute pancreatitis. World J Surg. 2012;36(7):1679–85.CrossRef O’Leary D, O’Neill D, McLaughlin P, O’Neill S, Myers E, Maher M, Redmond H. Effects of abdominal fat distribution parameters on severity of acute pancreatitis. World J Surg. 2012;36(7):1679–85.CrossRef
16.
Zurück zum Zitat Natu A, Stevens T, Kang L, Yasinow S, Mansoor E, Lopez R, Glessing B, Remer E, Richards T, Gupta A. Visceral adiposity predicts severity of acute pancreatitis. Pancreas. 2017;46(6):776–81.CrossRef Natu A, Stevens T, Kang L, Yasinow S, Mansoor E, Lopez R, Glessing B, Remer E, Richards T, Gupta A. Visceral adiposity predicts severity of acute pancreatitis. Pancreas. 2017;46(6):776–81.CrossRef
17.
Zurück zum Zitat Petrov MS. Editorial: abdominal fat: a key player in metabolic acute pancreatitis. Am J Gastroenterol. 2013;108(1):140–2.CrossRef Petrov MS. Editorial: abdominal fat: a key player in metabolic acute pancreatitis. Am J Gastroenterol. 2013;108(1):140–2.CrossRef
18.
Zurück zum Zitat Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–11.CrossRef Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–11.CrossRef
19.
Zurück zum Zitat Thoemmes F. Propensity score matching in SPSS. In: arXiv preprint arXiv:12016385; 2012. Thoemmes F. Propensity score matching in SPSS. In: arXiv preprint arXiv:12016385; 2012.
20.
Zurück zum Zitat Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23(10):1638–52.CrossRef Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23(10):1638–52.CrossRef
21.
Zurück zum Zitat Irlbeck T, Massaro J, Bamberg F, O'donnell C, Hoffmann U, Fox C. Association between single-slice measurements of visceral and abdominal subcutaneous adipose tissue with volumetric measurements: the Framingham heart study. Int J Obes. 2010;34(4):781.CrossRef Irlbeck T, Massaro J, Bamberg F, O'donnell C, Hoffmann U, Fox C. Association between single-slice measurements of visceral and abdominal subcutaneous adipose tissue with volumetric measurements: the Framingham heart study. Int J Obes. 2010;34(4):781.CrossRef
22.
Zurück zum Zitat Aubrey J, Esfandiari N, Baracos V, Buteau F, Frenette J, Putman C, Mazurak V. Measurement of skeletal muscle radiation attenuation and basis of its biological variation. Acta Physiol. 2014;210(3):489–97.CrossRef Aubrey J, Esfandiari N, Baracos V, Buteau F, Frenette J, Putman C, Mazurak V. Measurement of skeletal muscle radiation attenuation and basis of its biological variation. Acta Physiol. 2014;210(3):489–97.CrossRef
23.
Zurück zum Zitat Koda M, Senda M, Kamba M, Kimura K, Murawaki Y. Sonographic subcutaneous and visceral fat indices represent the distribution of body fat volume. Abdom Imaging. 2007;32(3):387–92.CrossRef Koda M, Senda M, Kamba M, Kimura K, Murawaki Y. Sonographic subcutaneous and visceral fat indices represent the distribution of body fat volume. Abdom Imaging. 2007;32(3):387–92.CrossRef
24.
Zurück zum Zitat Gronemeyer SA, Steen RG, Kauffman WM, Reddick WE, Glass JO. Fast adipose tissue (FAT) assessment by MRI. Magn Reson Imaging. 2000;18(7):815–8.CrossRef Gronemeyer SA, Steen RG, Kauffman WM, Reddick WE, Glass JO. Fast adipose tissue (FAT) assessment by MRI. Magn Reson Imaging. 2000;18(7):815–8.CrossRef
25.
Zurück zum Zitat Maurovich-Horvat P, Massaro J, Fox C, Moselewski F, O'donnell C, Hoffmann U. Comparison of anthropometric, area-and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes. 2007;31(3):500.CrossRef Maurovich-Horvat P, Massaro J, Fox C, Moselewski F, O'donnell C, Hoffmann U. Comparison of anthropometric, area-and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes. 2007;31(3):500.CrossRef
26.
Zurück zum Zitat Dobszai D, Mátrai P, Gyöngyi Z, Csupor D, Bajor J, Erőss B, Mikó A, Szakó L, Meczker Á, Hágendorn R. Body-mass index correlates with severity and mortality in acute pancreatitis: a meta-analysis. World J Gastroenterol. 2019;25(6):729.CrossRef Dobszai D, Mátrai P, Gyöngyi Z, Csupor D, Bajor J, Erőss B, Mikó A, Szakó L, Meczker Á, Hágendorn R. Body-mass index correlates with severity and mortality in acute pancreatitis: a meta-analysis. World J Gastroenterol. 2019;25(6):729.CrossRef
27.
Zurück zum Zitat Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311(8):806–14.CrossRef Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311(8):806–14.CrossRef
28.
Zurück zum Zitat Yang Y-X, Li L. Evaluating the ability of the bedside index for severity of acute pancreatitis score to predict severe acute pancreatitis: a meta-analysis. Med Princ Pract. 2016;25(2):137–42.CrossRef Yang Y-X, Li L. Evaluating the ability of the bedside index for severity of acute pancreatitis score to predict severe acute pancreatitis: a meta-analysis. Med Princ Pract. 2016;25(2):137–42.CrossRef
29.
Zurück zum Zitat Staubli SM, Oertli D, Nebiker CA. Laboratory markers predicting severity of acute pancreatitis. Crit Rev Clin Lab Sci. 2015;52(6):273–83.CrossRef Staubli SM, Oertli D, Nebiker CA. Laboratory markers predicting severity of acute pancreatitis. Crit Rev Clin Lab Sci. 2015;52(6):273–83.CrossRef
30.
Zurück zum Zitat Di M-Y, Liu H, Yang Z-Y, Bonis PA, Tang J-L, Lau J. Prediction models of mortality in acute pancreatitis in adults: a systematic review. Ann Intern Med. 2016;165(7):482–90.CrossRef Di M-Y, Liu H, Yang Z-Y, Bonis PA, Tang J-L, Lau J. Prediction models of mortality in acute pancreatitis in adults: a systematic review. Ann Intern Med. 2016;165(7):482–90.CrossRef
31.
Zurück zum Zitat Goyal H, Awad H, Hu Z-D. Prognostic value of admission red blood cell distribution width in acute pancreatitis: a systematic review. Annals of translational medicine. 2017;5(17).CrossRef Goyal H, Awad H, Hu Z-D. Prognostic value of admission red blood cell distribution width in acute pancreatitis: a systematic review. Annals of translational medicine. 2017;5(17).CrossRef
32.
Zurück zum Zitat Mounzer R, Langmead CJ, Wu BU, Evans AC, Bishehsari F, Muddana V, Singh VK, Slivka A, Whitcomb DC, Yadav D. Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology. 2012;142(7):1476–82.CrossRef Mounzer R, Langmead CJ, Wu BU, Evans AC, Bishehsari F, Muddana V, Singh VK, Slivka A, Whitcomb DC, Yadav D. Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology. 2012;142(7):1476–82.CrossRef
33.
Zurück zum Zitat Vege SS, DiMagno MJ, Forsmark CE, Martel M, Barkun AN. Initial medical treatment of acute pancreatitis: American Gastroenterological Association Institute technical review. Gastroenterology. 2018;154(4):1103–39.CrossRef Vege SS, DiMagno MJ, Forsmark CE, Martel M, Barkun AN. Initial medical treatment of acute pancreatitis: American Gastroenterological Association Institute technical review. Gastroenterology. 2018;154(4):1103–39.CrossRef
34.
Zurück zum Zitat Wang T, Ma X, Peng D, Zhang R, Sun X, Chen M, Yan J, Wang S, Yan D, He Z. Effects of obesity related genetic variations on visceral and subcutaneous fat distribution in a Chinese population. Sci Rep. 2016;6:20691.CrossRef Wang T, Ma X, Peng D, Zhang R, Sun X, Chen M, Yan J, Wang S, Yan D, He Z. Effects of obesity related genetic variations on visceral and subcutaneous fat distribution in a Chinese population. Sci Rep. 2016;6:20691.CrossRef
35.
Zurück zum Zitat Pulit SL, Karaderi T, Lindgren CM. Sexual dimorphisms in genetic loci linked to body fat distribution. Biosci Rep. 2017;37(1):BSR20160184.CrossRef Pulit SL, Karaderi T, Lindgren CM. Sexual dimorphisms in genetic loci linked to body fat distribution. Biosci Rep. 2017;37(1):BSR20160184.CrossRef
36.
Zurück zum Zitat Kanaley J, Sames C, Swisher L, Swick A, Ploutz-Snyder L, Steppan C, Sagendorf K, Feiglin D, Jaynes E, Meyer R. Abdominal fat distribution in pre-and postmenopausal women: the impact of physical activity, age, and menopausal status. Metabolism-Clinical and Experimental. 2001;50(8):976–82.CrossRef Kanaley J, Sames C, Swisher L, Swick A, Ploutz-Snyder L, Steppan C, Sagendorf K, Feiglin D, Jaynes E, Meyer R. Abdominal fat distribution in pre-and postmenopausal women: the impact of physical activity, age, and menopausal status. Metabolism-Clinical and Experimental. 2001;50(8):976–82.CrossRef
37.
Zurück zum Zitat Yoneshiro T, Aita S, Matsushita M, Okamatsu-Ogura Y, Kameya T, Kawai Y, Miyagawa M, Tsujisaki M, Saito M. Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans. Obesity. 2011;19(9):1755–60.CrossRef Yoneshiro T, Aita S, Matsushita M, Okamatsu-Ogura Y, Kameya T, Kawai Y, Miyagawa M, Tsujisaki M, Saito M. Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans. Obesity. 2011;19(9):1755–60.CrossRef
38.
Zurück zum Zitat Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the national VA surgical risk study. Arch Surg. 1999;134(1):36–42.CrossRef Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the national VA surgical risk study. Arch Surg. 1999;134(1):36–42.CrossRef
39.
Zurück zum Zitat Blamey S, Imrie C, O'neill J, Gilmour W, Carter DC. Prognostic factors in acute pancreatitis. Gut. 1984;25(12):1340–6.CrossRef Blamey S, Imrie C, O'neill J, Gilmour W, Carter DC. Prognostic factors in acute pancreatitis. Gut. 1984;25(12):1340–6.CrossRef
Metadaten
Titel
Impact of visceral adiposity on severity of acute pancreatitis: a propensity score-matched analysis
verfasst von
Jiarong Xie
Lu Xu
Yuning Pan
Peifei Li
Yi Liu
Yue Pan
Lei Xu
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Gastroenterology / Ausgabe 1/2019
Elektronische ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-019-1015-z

Weitere Artikel der Ausgabe 1/2019

BMC Gastroenterology 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.